Journal profile · Medicine-Public Health, Environmental and Occupational Health
Infection Prevention in Practice
ISSN 2590-0889 · Elsevier · United Kingdom
Infection Prevention in Practice: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.6 (journal website); fully open access; APC about USD 1,500; median 144 days to acceptance (101 articles, last 24 months); 65 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Infection Prevention in Practice is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Infection Control in Healthcare, Nosocomial Infections in ICU and Antibiotic Use and Resistance, together about 34% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
An Official Journal of the Healthcare Infection Society Infection Prevention in Practice (IPIP), an open access companion title to the respected Journal of Hospital Infection, is the editorially independent online journal of the Healthcare Infection Society (HIS). IPIP provides a comprehensive fully open access resource for all those working in the field of prevention and treatment of healthcare-associated infections (HCAIs) worldwide.In accordance with the charitable aims of the HIS, this fully open access online journal maximises the discoverability of latest research related to all aspects of infection. Fair article processing charges ensure publication in IPIP is also increasingly accessible to those authors (irrespective of funding) who wish to publish in a high quality, independently peer-reviewed journal.IPIP welcomes high quality articles (in the form of local research studies, experiences, case reports, novel techniques, best practice and outbreak reports) in the field of infection prevention and control (IPC) that will influence clinical best practice and reduce the global burden of infection in healthcare. Articles should relate to HCAIs, either directly or indirectly, and should provide practical information to healthcare professionals working in the field of IPC that is applicable on a global or regional scale. We are particularly interested in papers that provide unique insight into the challenges of preventing HCAIs in developing countries. All submissions are subject to a rigorous single-blind peer review process.We encourage submissions in the following areas:Antimicrobial stewardship (including antivirals and antifungals)Diagnostic stewardship and impact on infection prevention controlLocal hospital surveys and research in clinical infectionsLocal epidemiological and environmental studies of infectious agentsNovel infectious agent descriptions, strain characterisation and case reports that relate to HCAIsNovel treatments for HCAIs, including clinical trialsInfection prevention and control challenges in developing countriesHospital and community healthcare management and resourcesHealthcare environments and building designOutbreaks - surveillance, management and learning pointsResearch methodology and ethical considerationsVaccines that relate to HCAIsIPC outreach and educational activitiesPublic health interventions in infectionClinical diagnosis of HCAIs
From the journal's Aims & Scope
Research area (LetPub): Medicine-Public Health, Environmental and Occupational Health
Editor-in-chief Gemma WinzorPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 10, United States 5, Australia 4, Hong Kong, China 2, India 2 (29 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Infection Control in HealthcareMedicine15%
- Nosocomial Infections in ICUMedicine9.6%
- Antibiotic Use and ResistanceImmunology and Microbiology9.3%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology8.8%
- Infection Control and VentilationMedicine8.4%
- Surgical site infection preventionMedicine6.4%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology4.2%
- Antimicrobial Resistance in StaphylococcusMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Public, Environmental & Occupational Health | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.6Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- CiteScore (publisher)
- 3.5Publisher website ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 0.91LetPub ·
- h-index
- 28OpenAlex ·
- i10-index
- 114OpenAlex ·
- 2-year mean citedness
- 2.4OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 52LetPub ·
Articles by year OpenAlex count · 548 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 90 | 90 | 20 |
| 2025 | 65 | 65 | 109 |
| 2024 | 92 | 92 | 464 |
| 2023 | 62 | 62 | 478 |
| 2022 | 61 | 61 | 453 |
| 2021 | 81 | 81 | 869 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
144 daysMedian, submission to acceptance · P25–P75 99 days – 210 days
- Acceptance to online
- median 10 days (101 articles)
- Submission to online
- median 155 days
- Sample
- 101 articles with submission and acceptance dates (169 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- First decision after review
- 55 daysPublisher website ·
- Submission to acceptance
- 168 daysPublisher website ·
- Acceptance to publication
- 10 daysPublisher website ·
- Submission to publication (journal-reported)
- about 30 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,500 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 1,500 / EUR 1,400 / GBP 1,200 / JPY 186,050 | — | — | |
| LetPub | USD 1,245 | Yes | — | |
| Publisher website | USD 1,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteArticle types accepted9, with length limits
- case reportAll Case Report submissions should have written informed consent and include the statement "Written informed consent has been given and retained by authors". Ca…Length not stated
- case reportsCase Reports All Case Report submissions should have written informed consentLength not stated
- editorialIPIP will consider publishing other article types that are relevant to infection prevention practice. We ask authors to check with the editorial office beforeha…Length not stated
- letters to the editorWe welcome letters relating to, or responding to, recently published items in the journal. Where appropriate, these will be shown to the authors of the original…main text ≤ 800 words
- original research articlehance your scientific research. If your original research article is under 2000 words, you may wish to consider a shorter, unstructured summary,main text ≤ 2,000 words
- other article typesIPIP will consider publishing other article types that are relevant to infection prevention practice.Length not stated
- reviewWe welcome both general reviews, that summarize the current understanding and research on a topic, and systematic reviews, that provide a thorough critical asse…main text ≤ 250 words
- reviewsIPIP invites articles of the following types: ReviewsLength not stated
- short reportIPIP invites articles of the following types: Short ReportLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Author contributions
For transparency, we encourage corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administratio…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of compe…
Source ↗Publisher website ·- License & copyright Copyright
Authors complete a License Agreement upon acceptance. Model summary
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about our open access fees, the Healthcare Infection Society discount and eligibility criteria for fee waivers.
Source ↗Publisher website ·- Peer review Peer Review and Editorial Process
Your submission will be received by the Editorial office.Papers that are submitted without all Author's hand signed signatures or with references or other features that do not comply with the instructions to authors will be returned to their authors and will not be considered for publication until they have been corrected and resubmitted.You will receive an acknowledgement by email containing your…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed anywhere at any time; does not count as prior publication. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2590-0889
- Society / sponsor
- Healthcare Infection Society Infection Prevention in Practice
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Infection Prevention in Practice
What CAS zone is Infection Prevention in Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Infection Prevention in Practice is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases / Public, Environmental & Occupational Health. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Infection Prevention in Practice?
The journal's website gives an impact factor of 2.6; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.5, h-index 28.
How long does peer review take at Infection Prevention in Practice?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 144 days (interquartile range 99–210 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Infection Prevention in Practice based?
Of the 29 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (10), United States (5) and Australia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Infection Prevention in Practice?
According to LetPub and DOAJ records, Infection Prevention in Practice is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Infection Prevention in Practice open access, and what is the APC?
Infection Prevention in Practice is a fully open-access journal. APC about USD 1,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .